11.19% to Target, Bank of America Reiterates Buy Rating for Zendesk (ZEN) Stock; Select Medical (SEM) Has 1.27 Sentiment

Among 21 analysts covering Zendesk (NYSE:ZEN), 18 have Buy rating, 0 Sell and 3 Hold. Therefore 86% are positive. Zendesk has $48 highest and $25.0 lowest target. $36.95’s average target is -8.70% below currents $40.47 stock price. Zendesk had 54 analyst reports since August 5, 2015 according to SRatingsIntel. On Friday, September 11 the stock rating was upgraded by Credit Suisse to “Outperform”. RBC Capital Markets initiated the stock with “Outperform” rating in Friday, September 11 report. RBC Capital Markets maintained Zendesk, Inc. (NYSE:ZEN) on Wednesday, January 17 with “Buy” rating. The firm has “Buy” rating given on Tuesday, August 8 by Canaccord Genuity. Wells Fargo initiated the stock with “Outperform” rating in Wednesday, January 11 report. As per Sunday, October 8, the company rating was maintained by RBC Capital Markets. Piper Jaffray maintained it with “Buy” rating and $3300 target in Friday, August 4 report. Guggenheim maintained Zendesk, Inc. (NYSE:ZEN) rating on Wednesday, April 19. Guggenheim has “Buy” rating and $33 target. The firm has “Overweight” rating by Morgan Stanley given on Thursday, November 2. The rating was downgraded by Stephens to “Sell” on Monday, October 9.

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company has market cap of $2.31 billion. The companyÂ’s Specialty Hospitals segment operates long term acute care hospitals and inpatient acute rehabilitative hospitals. It has a 23.96 P/E ratio. This segment offers various medical services for the treatment of respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders, and cancer.

Analysts await Select Medical Holdings Corporation (NYSE:SEM) to report earnings on February, 22. They expect $0.19 earnings per share, up 58.33% or $0.07 from last year’s $0.12 per share. SEM’s profit will be $25.42 million for 22.70 P/E if the $0.19 EPS becomes a reality. After $0.14 actual earnings per share reported by Select Medical Holdings Corporation for the previous quarter, Wall Street now forecasts 35.71% EPS growth.

North Tide Capital Llc holds 18.43% of its portfolio in Select Medical Holdings Corporation for 4.50 million shares. Smith Graham & Co. Investment Advisors Lp owns 671,617 shares or 1.35% of their US portfolio. Moreover, Hood River Capital Management Llc has 1.26% invested in the company for 1.03 million shares. The New York-based Brigade Capital Management Lp has invested 1.25% in the stock. Deerfield Management Co, a New York-based fund reported 1.19 million shares.

The stock increased 1.77% or $0.3 during the last trading session, reaching $17.25. About 645,974 shares traded. Select Medical Holdings Corporation (SEM) has risen 12.50% since February 8, 2017 and is uptrending. It has underperformed by 4.20% the S&P500.

The stock increased 5.31% or $2.04 during the last trading session, reaching $40.47. About 4.51M shares traded or 438.57% up from the average. Zendesk, Inc. (NYSE:ZEN) has risen 6.73% since February 8, 2017 and is uptrending. It has underperformed by 9.97% the S&P500.

Analysts await Zendesk, Inc. (NYSE:ZEN) to report earnings on February, 14. They expect $-0.27 EPS, down 12.50% or $0.03 from last year’s $-0.24 per share. After $-0.26 actual EPS reported by Zendesk, Inc. for the previous quarter, Wall Street now forecasts 3.85% negative EPS growth.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter: